KORU Medical Systems, Inc. (KRMD)

KORU Medical Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	33.65	28.52	27.9	23.49	24.18
Revenue Growth (YoY)	17.98%	2.23%	18.76%	-2.84%	4.38%
Cost of Revenue	12.31	11.81	12.53	9.72	9.24
Gross Profit	21.33	16.71	15.37	13.77	14.94
Selling, General & Admin	21.63	20.37	20.61	17.86	12.03
Research & Development	5.26	5.74	4.96	2.47	1.3
Operating Expenses	27.78	26.98	26.15	20.8	13.74
Operating Income	-6.45	-10.27	-10.78	-7.03	1.19
Interest & Investment Income	0.44	0.56	0.15	0.01	0.04
Currency Exchange Gain (Loss)	-0.05	-0.01	-0.04	-0.03	0
Other Non Operating Income (Expenses)	-	-	-	0.68	-
EBT Excluding Unusual Items	-6.05	-9.71	-10.68	-6.37	1.24
Gain (Loss) on Sale of Assets	-0.02	-0.06	-	0	0.02
Legal Settlements	-	-	-	-	-2.45
Pretax Income	-6.06	-9.77	-10.68	-6.36	-1.19
Income Tax Expense	0	3.97	-2.01	-1.8	0.02
Net Income	-6.07	-13.74	-8.66	-4.56	-1.21
Net Income to Common	-6.07	-13.74	-8.66	-4.56	-1.21
Shares Outstanding (Basic)	46	46	45	44	42
Shares Outstanding (Diluted)	46	46	45	44	42
Shares Change (YoY)	0.44%	1.33%	1.39%	5.86%	7.34%
EPS (Basic)	-0.13	-0.30	-0.19	-0.10	-0.03
EPS (Diluted)	-0.13	-0.30	-0.19	-0.10	-0.03
Free Cash Flow	-1.62	-5.68	-8.17	-4.67	-1.66
Free Cash Flow Per Share	-0.04	-0.12	-0.18	-0.10	-0.04
Gross Margin	63.40%	58.59%	55.09%	58.62%	61.78%
Operating Margin	-19.16%	-36.01%	-38.65%	-29.93%	4.93%
Profit Margin	-18.03%	-48.18%	-31.05%	-19.42%	-5.01%
Free Cash Flow Margin	-4.81%	-19.90%	-29.27%	-19.86%	-6.88%
EBITDA	-5.67	-9.4	-10.19	-6.57	1.61
EBITDA Margin	-16.86%	-32.96%	-36.54%	-27.95%	6.66%
D&A For EBITDA	0.77	0.87	0.59	0.46	0.42
EBIT	-6.45	-10.27	-10.78	-7.03	1.19
EBIT Margin	-19.16%	-36.01%	-38.65%	-29.93%	4.93%

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q